Is hyperprogressive disease a specific phenomenom of immunotherapy?
Hyperprogressive disease (HPD) is a novel pattern of response during immunotherapy treatment. Several retrospective studies have evaluated its prevalence among various cancer types and, in particular, in non-small cell lung cancer patients, based on different definition criteria. If HPD is a just a...
Saved in:
Main Authors: | Marta Brambilla (Author), Giuseppe Lo Russo (Author), Roberto Ferrara (Author), Sara Manglaviti (Author), Marina Chiara Garassino (Author), Mario Occhipinti (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperprogression after immunotherapy in HNC: literature review and our experience
by: Nerina Denaro
Published: (2018) -
Is there an association between lymph node size and hyperprogression in immunotherapy-treated patients?
by: Alkader Mohammad S., et al.
Published: (2024) -
Fatal Lucio's phenomenom: an autopsy case report
by: Fernando Peixoto Ferraz de Campos, et al.
Published: (2011) -
Molluscum Contagiosum Induced Reverse Isotopic Phenomenom
by: A. Casanova-Esquembre, et al.
Published: (2023) -
Exploration of genetic characterization in hyperprogressive disease after immunotherapy retreatment in a patient with LCNEC: A case report
by: Yao Zhang, et al.
Published: (2024)